Cipla Quality Chemical industries
Manufacturer of antiretroviral drugs (ARVs) and artemisinin-based combination therapies (ACTs) to combat HIV/AIDS and Malaria respectively.
Employees
Enterprise value
$49m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | $34.8m | Post IPO Debt | |
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.